Huapont Life Sciences Co.,Ltd. (SHE:002004)
China
· Delayed Price · Currency is CNY 4.980
+0.050 (1.01%)
Apr 29, 2026, 3:04 PM CST
Huapont Life Sciences Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 9,726 | 9,430 | 8,918 | 9,226 | 10,098 | 14,335 | Upgrade
|
| Market Cap Growth | 21.12% | 5.75% | -3.35% | -8.63% | -29.56% | 30.69% | Upgrade
|
| Enterprise Value | 19,802 | 20,338 | 20,417 | 19,628 | 19,449 | 22,886 | Upgrade
|
| Last Close Price | 4.93 | 4.78 | 4.34 | 4.26 | 4.46 | 6.08 | Upgrade
|
| PE Ratio | 14.22 | 13.22 | - | 30.54 | 23.29 | 21.47 | Upgrade
|
| Forward PE | - | 23.63 | 23.63 | 23.63 | 23.63 | 23.63 | Upgrade
|
| PS Ratio | 0.85 | 0.82 | 0.77 | 0.80 | 0.76 | 1.15 | Upgrade
|
| PB Ratio | 0.56 | 0.56 | 0.58 | 0.56 | 0.61 | 0.91 | Upgrade
|
| P/TBV Ratio | 1.41 | 1.41 | 1.54 | 1.60 | 1.83 | 2.90 | Upgrade
|
| P/FCF Ratio | 5.73 | 6.47 | 13.33 | 30.22 | 7.91 | 1086.87 | Upgrade
|
| P/OCF Ratio | 4.28 | 4.50 | 5.49 | 5.81 | 4.19 | 11.29 | Upgrade
|
| PEG Ratio | - | 1.12 | 1.12 | 1.12 | 1.12 | 1.12 | Upgrade
|
| EV/Sales Ratio | 1.72 | 1.77 | 1.75 | 1.69 | 1.47 | 1.84 | Upgrade
|
| EV/EBITDA Ratio | 7.54 | 8.03 | 10.23 | 9.07 | 7.35 | 10.40 | Upgrade
|
| EV/EBIT Ratio | 12.84 | 13.49 | 19.11 | 15.02 | 10.37 | 15.42 | Upgrade
|
| EV/FCF Ratio | 11.66 | 13.95 | 30.52 | 64.28 | 15.23 | 1735.25 | Upgrade
|
| Debt / Equity Ratio | 0.46 | 0.43 | 0.57 | 0.52 | 0.49 | 0.57 | Upgrade
|
| Debt / EBITDA Ratio | 3.06 | 2.83 | 4.38 | 3.92 | 3.01 | 4.02 | Upgrade
|
| Debt / FCF Ratio | 4.73 | 4.99 | 13.29 | 28.25 | 6.30 | 679.94 | Upgrade
|
| Net Debt / Equity Ratio | 0.18 | 0.20 | 0.22 | 0.18 | 0.14 | 0.19 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.21 | 1.35 | 1.70 | 1.39 | 0.89 | 1.34 | Upgrade
|
| Net Debt / FCF Ratio | 1.85 | 2.35 | 5.07 | 9.88 | 1.85 | 223.34 | Upgrade
|
| Asset Turnover | 0.39 | 0.39 | 0.39 | 0.38 | 0.44 | 0.43 | Upgrade
|
| Inventory Turnover | 3.49 | 3.40 | 3.18 | 2.77 | 3.23 | 3.57 | Upgrade
|
| Quick Ratio | 0.94 | 0.78 | 0.83 | 0.78 | 0.77 | 0.82 | Upgrade
|
| Current Ratio | 1.40 | 1.26 | 1.08 | 1.07 | 1.04 | 1.08 | Upgrade
|
| Return on Equity (ROE) | 5.33% | 5.43% | -2.14% | 4.09% | 6.96% | 6.14% | Upgrade
|
| Return on Assets (ROA) | 3.23% | 3.22% | 2.22% | 2.69% | 3.90% | 3.18% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.22% | 6.40% | 5.56% | 5.15% | 6.92% | 5.73% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.40% | 7.60% | 5.60% | 6.50% | 9.90% | 8.00% | Upgrade
|
| Earnings Yield | 7.03% | 7.56% | -3.35% | 3.28% | 4.29% | 4.66% | Upgrade
|
| FCF Yield | 17.46% | 15.46% | 7.50% | 3.31% | 12.64% | 0.09% | Upgrade
|
| Dividend Yield | 10.10% | - | - | 5.17% | 4.93% | 3.62% | Upgrade
|
| Payout Ratio | 95.82% | 93.73% | - | 250.32% | 197.10% | 128.69% | Upgrade
|
| Buyback Yield / Dilution | 0.05% | 0.10% | 0.25% | 0.02% | -0.02% | -0.25% | Upgrade
|
| Total Shareholder Return | 10.15% | 0.10% | 0.25% | 5.19% | 4.91% | 3.37% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.